Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective

Overview

Journal Obes Surg

Date 2013 Apr 9

PMID 23564465

Citations 10

Authors

Ricardo Cohen

Pedro Paulo Caravatto

Tarissa Petry

Affiliations

Soon will be listed here.

Abstract

Bariatric surgery was developed with the aim of weight reduction. Success was defined only by excess weight loss. Other indices of resolution of metabolic comorbidities were reported, but were mostly secondary. Several communications have reported that regardless of body mass index (BMI), complete or partial remission of type 2 diabetes mellitus (T2DM) is possible. These results mostly occur before weight loss, positioning metabolic surgery as a good tool for controlling the current T2DM epidemic. Medical treatment is evolving, but is expensive and not risk-free. Surgery aimed mainly at diseases such as diabetes and not weight loss are referred to as "metabolic surgery." Metabolic surgery has been proven to be safe and effective, and although more data are needed, it is unquestionable that a new discipline has been founded. Metabolic surgery can effectively treat T2DM in individuals with any BMI, including that below 35 kg/m(2).

Citing Articles

Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up.

Kermansaravi M, Valizadeh R, Shahsavan M, Adel Maleknia S, Eghbali F, Pazouki A BMC Surg. 2024; 24(1):6.

PMID: 38172751 PMC: 10765846. DOI: 10.1186/s12893-023-02295-x.

Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement.

Haddad A, Kow L, Herrera M, Cohen R, Himpens J, Greve J Obes Surg. 2022; 32(10):3217-3230.

PMID: 35922610 DOI: 10.1007/s11695-022-06220-8.

Metabolic surgery: gastric bypass for the treatment of type 2 diabetes mellitus.

Quevedo M, Palermo M, Serra E, Ackermann M Transl Gastroenterol Hepatol. 2017; 2:58.

PMID: 28713862 PMC: 5504088. DOI: 10.21037/tgh.2017.05.10.

Changing Guidelines for Metabolic Surgery: Now It's the Time!.

Caravatto P, Petry T, Cohen R Curr Atheroscler Rep. 2016; 18(8):47.

PMID: 27315085 DOI: 10.1007/s11883-016-0600-7.

The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease.

Cavicchioli M, Guerbali C, Ochiai C, Silva R, Camara G, Petry T Curr Atheroscler Rep. 2016; 18(7):44.

PMID: 27260145 DOI: 10.1007/s11883-016-0591-4.

References

Dixon J, OBrien P, Playfair J, Chapman L, Schachter L, Skinner S . Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299(3):316-23. DOI: 10.1001/jama.299.3.316. View

Lautz D, Halperin F, Goebel-Fabbri A, Goldfine A . The great debate: medicine or surgery: what is best for the patient with type 2 diabetes?. Diabetes Care. 2011; 34(3):763-70. PMC: 3041223. DOI: 10.2337/dc10-1859. View

Rubino F, Marescaux J . Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2003; 239(1):1-11. PMC: 1356185. DOI: 10.1097/01.sla.0000102989.54824.fc. View

Cummings B, Strader A, Stanhope K, Graham J, Lee J, Raybould H . Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology. 2010; 138(7):2437-46, 2446.e1. PMC: 2883638. DOI: 10.1053/j.gastro.2010.03.005. View

Scopinaro N, Adami G, Papadia F, Camerini G, Carlini F, Fried M . Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011; 253(4):699-703. DOI: 10.1097/SLA.0b013e318203ae44. View

Mamtani R, Haynes K, Bilker W, Vaughn D, Strom B, Glanz K . Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst. 2012; 104(18):1411-21. PMC: 3529598. DOI: 10.1093/jnci/djs328. View

Dixit A, Pandey P . Rosiglitazone and pioglitazone. Beware fractures. BMJ. 2009; 339:b3957. DOI: 10.1136/bmj.b3957. View

Christou N, Sampalis J, Liberman M, Look D, Auger S, McLean A . Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240(3):416-23. PMC: 1356432. DOI: 10.1097/01.sla.0000137343.63376.19. View

Polonsky K . The past 200 years in diabetes. N Engl J Med. 2012; 367(14):1332-40. DOI: 10.1056/NEJMra1110560. View

10.

Sternthal E . Incretin-based therapy and pancreatitis-what is the risk?. Endocr Pract. 2011; 17(3):334-6. DOI: 10.4158/EP11126.ED. View

11.

Lee W, Chong K, Ser K, Lee Y, Chen S, Chen J . Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011; 146(2):143-8. DOI: 10.1001/archsurg.2010.326. View

12.

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

13.

Anderson J, Konz E, Frederich R, Wood C . Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001; 74(5):579-84. DOI: 10.1093/ajcn/74.5.579. View

14.

Cummings D, Flum D . Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008; 299(3):341-3. DOI: 10.1001/jama.299.3.341. View

15.

Zhu Z, Shen Z, Lu Y, Zhong S, Xu C . Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2012; 98(1):159-63. DOI: 10.1016/j.diabres.2012.05.006. View

16.

Kopec K, Kowalski M . Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship. J Med Toxicol. 2012; 9(1):61-6. PMC: 3576503. DOI: 10.1007/s13181-012-0278-3. View

17.

Sinha A, Rajan M, Hoerger T, Pogach L . Costs and consequences associated with newer medications for glycemic control in type 2 diabetes. Diabetes Care. 2010; 33(4):695-700. PMC: 2845008. DOI: 10.2337/dc09-1488. View

18.

Rubino F, Kaplan L, Schauer P, Cummings D . The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2009; 251(3):399-405. DOI: 10.1097/SLA.0b013e3181be34e7. View

19.

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008; 32(1):193-203. PMC: 2606813. DOI: 10.2337/dc08-9025. View

20.

Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K . Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008; 168(15):1609-16. DOI: 10.1001/archinte.168.15.1609. View